Insider Transactions in Q2 2025 at Scholar Rock Holding Corp (SRRK)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Junlin Ho GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
7,442
-3.24%
|
$238,144
$32.0 P/Share
|
|
Jun 16
2025
|
Caryn Parlavecchio CHRO |
SELL
Open market or private sale
|
Direct |
6,186
-3.78%
|
$197,952
$32.0 P/Share
|
|
Jun 16
2025
|
Mo Qatanani CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
3,668
-2.56%
|
$117,376
$32.0 P/Share
|
|
Jun 16
2025
|
Katie Peng |
SELL
Open market or private sale
|
Direct |
3,031
-4.0%
|
$96,992
$32.24 P/Share
|
|
Jun 09
2025
|
Junlin Ho GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
8,571
+3.59%
|
-
|
|
May 29
2025
|
Akshay Vaishnaw President of R&D |
SELL
Open market or private sale
|
Direct |
6,750
-0.54%
|
$195,750
$29.82 P/Share
|
|
May 29
2025
|
Joshua Reed |
SELL
Open market or private sale
|
Direct |
5,400
-13.13%
|
$156,600
$29.86 P/Share
|
|
May 29
2025
|
Richard Brudnick |
SELL
Open market or private sale
|
Direct |
6,075
-15.31%
|
$176,175
$29.82 P/Share
|
|
May 29
2025
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
3,375
-2.91%
|
$97,875
$29.53 P/Share
|
|
May 29
2025
|
Kristina Burow |
SELL
Open market or private sale
|
Direct |
5,400
-10.53%
|
$156,600
$29.54 P/Share
|
|
May 29
2025
|
Jeffrey S. Flier |
SELL
Open market or private sale
|
Direct |
6,075
-10.39%
|
$176,175
$29.54 P/Share
|
|
May 22
2025
|
Kristina Burow |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+22.38%
|
-
|
|
May 22
2025
|
Joshua Reed |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+26.53%
|
-
|
|
May 22
2025
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+26.53%
|
-
|
|
May 22
2025
|
Michael Gilman |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+11.52%
|
-
|
|
May 22
2025
|
Katie Peng |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+16.74%
|
-
|
|
May 22
2025
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+26.53%
|
-
|
|
May 22
2025
|
Jeffrey S. Flier |
BUY
Grant, award, or other acquisition
|
Direct |
7,632
+20.2%
|
-
|
|
Apr 27
2025
|
Keith Woods Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+47.73%
|
-
|
|
Apr 27
2025
|
Vikas Sinha Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+47.73%
|
-
|
|
Apr 27
2025
|
David Hallal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+36.01%
|
-
|
|
Apr 27
2025
|
Akshay Vaishnaw President of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+44.69%
|
-
|
|
Apr 25
2025
|
Tracey Sacco Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.26%
|
$165,000
$33.15 P/Share
|
|
Apr 25
2025
|
Tracey Sacco Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.15%
|
$50,000
$10.0 P/Share
|